In multivariate analyses, factors associated with poorer outcome were high IPI score, expression of HOXA9 and CCR6, absence of chemotherapy, and BLS-type DLBCL (Table 1). The gene discussed is CCR6; the disease is diffuse large B-cell lymphoma.